Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor

We recently demonstrated that endoplasmic reticulum (ER) stress induces sigma-1 receptor (Sig-1R) expression through the PERK pathway, which is one of the cell's responses to ER stress. In addition, it has been demonstrated that induction of Sig-1R can repress cell death signaling. Fluvoxamine (Fly) is a selective serotonin reuptake inhibitor (SSRI) with a high affinity for Sig-1R. In the present study, we show that treatment of neuroblastoma cells with Fly induces Sig-1R expression by increasing ATF4 translation directly, through its own activation, without involvement of the PERK pathway. The Fly-mediated induction of Sig-1R prevents neuronal cell death resulting from ER stress. Moreover, Fly-induced ER stress resistance reduces the infarct area in mice after focal cerebral ischemia. Thus, Fly, which is used frequently in clinical practice, can alleviate ER stress. This suggests that Fly could be a feasible therapy for cerebral diseases caused by ER stress.